Bluejay Diagnostics, Inc. Increase (Decrease) in Deferred Charges
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Deferred Charges of $101.17 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2026-03-06
- Bluejay Diagnostics, Inc. increase (decrease) in deferred charges for the quarter ending 2024-12-31 was $0.00.
- Bluejay Diagnostics, Inc. increase (decrease) in deferred charges for the quarter ending 2024-09-30 was $0.00.
- Bluejay Diagnostics, Inc. increase (decrease) in deferred charges for the quarter ending 2024-06-30 was $0.00.
- Bluejay Diagnostics, Inc. increase (decrease) in deferred charges for the quarter ending 2024-03-31 was -$265.08K.
- Bluejay Diagnostics, Inc. increase (decrease) in deferred charges for fiscal 2024 was -$265.08K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2025-09-30 | $101.17K 10-Q · filed 2025-11-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $0.00 derived: sum of 2 quarters · filed 2026-03-06 | $0.00 derived: sum of 3 quarters · filed 2026-03-06 | -$265.08K 10-K · filed 2026-03-06 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | -$265.08K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$265.08K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$265.08K 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |